You are here

Home › Listings › Life Sciences › Supreme Pharmaceuticals Inc.

Supreme Pharmaceuticals Inc.

Supreme Pharmaceuticals Inc.
Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
SL
CSE Index: 
Currency: 

Supreme Pharmaceuticals Inc. ("Supreme") (CSE:SL; OTCBB:SPRWF) is a publicly traded marijuana company based in Toronto, Canada. Supreme’s wholly owned subsidiary, 7ACRES/AMMcan, was issued a Canadian federal license to cultivate medical marijuana pursuant to the Marihuana for Medical Purposes Regulations on March 11, 2016 (now the ACMPR). Supreme is one of the newest marijuana Licensed Producers (LP) in Canada’s marijuana market, and is well positioned with its high capacity innovative hybrid greenhouse and B2B focused business model.

You are here

Home

Supreme Pharmaceuticals Inc. (SL)

SEDAR Information

Search form

Company Info

Address
202-20 De Boers Drive
Toronto, ON M3J 0H1
Canada
Phone
416-630-7272
Fax
--
Email
info@supreme.ca
Website
http://www.supreme.ca
Listing date
Monday, April 21, 2014

Capitalization

Issued & Outstanding: 
154738782
Reserved for Issuance: 
96765713

News Releases

08/05/2017

Supreme Updates Board of Directors and Provides Licensing Update

10/04/2017

Supreme Announces Conditional Approval to List on TSX.V

Bulletins

01/06/2017

2017-0601 - Delist - Supreme Pharmaceuticals Inc. (SL)

June 1, 2017

The common shares of Supreme Pharmaceuticals Inc. will be delisted at the market close, June 5, 2017.

Supreme Pharmaceuticals will continue to trade on the TSX Venture Exchange.

Date: Market close, June 5, 2017
Symbol: SL

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

CSE Filings

Form 7 April 2017.

Form 7 March 2017.

Form 7 February 2017.

Form 7 January 2017.

Form 7 December 2016.